Abstract
To detect altered gene expression associated with mouse lung tumor progression, we compared the gene expression profile of lung adenocarcinomas with that of lung adenomas and normal lungs. Autoradiographic analysis showed that among the 588 genes surveyed, 152 genes were detected and the remaining 436 genes did not give any signals. A gene-specific semiquantitative reverse transcription polymerase chain reaction method was used to confirm the expression profile. A total of 29 genes was found to be differentially expressed in mouse lung tumors when compared to normal lungs. The pattern of expression, either underexpression or overexpression, was the same for 10 genes between adenocarcinomas and adenomas. Among them, seven genes were overexpressed, two genes were underexpressed and one gene was lost. Interestingly, 19 genes showed differential expression or increased incidence or difference in level of change between lung adenomas and adenocarcinomas, including Stat1, ADAP, IGFBP-6, PDGF-A, TGF-β2, Int-3, VEGFR2, BAX, BAG-1, c-Jun, FasL, TRAIL, YB-1, CD31, Cdc42, B-raf, Rab-2, Abi-1, and ACE. These genes can be designated as candidate ‘lung tumor progression’ (LTP) genes because their expression changes may specifically affect lung tumor progression in mice. Further analyses of these candidate LTP genes may provide new leads for elucidation of lung tumor progression in mice.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bennett WP, Colby TV, Travis WD, Borkowski A, Tones RT, Lane DD, Metcalf RA, Samet JM, Takeshima Y, Gu JR, Vähäkangas KH, Soini Y, Pääkkö P, Welsh JA, Trump BF, Harris CC . 1993 Cancer Res. 53: 4817–4822
Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR . 1991 Cell 65: 1053–1061
Chiba I, Takashi T, Nau MM, D'Amico D, Curiel DT, Mitsudomi T, Buchhagen DL, Carbone D, Piantadosi S, Koga H, Reissman PT, Slamon DJ, Holmes EC, Minna JD . 1990 Oncogene 5: 1603–1610
Crews CM, Alessandrini A, Erikson RL . 1992 Cell Growth Diff. 3: 135–142
DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM . 1996 Nature Genet. 14: 457–460
Frank DA . 1999 Mol Med. 5: 432–456
Gazdar AF, Bader S, Hung J, Kishimoto Y, Sekido Y, Sugio K, Virmani A, Fleming J, Carbone DP, Minna JD . 1994 Cold Spring Harb. Symp. Quant. Biol. 59: 565–572
Gemma A, Takenaka K, Hosoya Y, Matuda K, Seike M, Kurimoto F, Ono Y, Uematsu K, Takeda Y, Hibino S, Yoshimura A, Shibuya M, Kudoh S . 2001 Eur. J. Cancer 37: 1554–1561
Geng Y, Weinberg RA . 1993 Proc. Natl. Acad. Sci. USA 90: 10315–10319
Hai T, Curran T . 1991 Proc. Natl. Acad. Sci. USA 88: 3720–3724
Herzog CR, Lubet RA, You M . 1997 J. Cell Biochem. Suppls. 28/29: 49–63
Imatani A, Callahan R . 2000 Oncogene 19: 223–231
Kishimoto Y, Sugio K, Hung JY, Virmani AK, McIntire DD, Minna JD, Gazdar AF . 1995 J. Natl. Cancer Inst. 87: 1224–1229
Kleef J, Korc M . 1998 J. Biol. Chem. 273: 7495–7500
Kjøller L, Hall L . 1999 Exp. Cell. Res. 253: 166–179
Kyriakis JM, App H, Zhang XF, Banerjee P, Brautigan DL, Rapp UR, Avruch J . 1992 Nature 358: 417–421
Li JM, Nichols MA, Chandrasekharan S, Xiong Y, Wang XF . 1995 J. Biol. Chem. 270: 26750–26753
Lin L, Wang Y, Bergman G, Kelloff GJ, Lubet RA, You M . 2001 Exp. Lung Res. 27: 217–229
Ludlow JW, Glendening DM, Livingston DM, DeCaprio JA . 1993 Mol. Cell Biol. 13: 367–372
Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D . 1995 Nat. Med. 1: 686–692
Mielnicki LM, Hughes RG, Chevray PM, Pruitt SC . 1996 Biochem. Biophys. Res. Commun. 228: 586–595
Minna JD, Glatstein EJ, Pass HI, Ihde DC . 1989 Cancer of lung pp 591–750 Philadelphia: Lippincott
Oltvai ZN, Milliman CL, Korsmeyer SJ . 1993 Cell 74: 609–619
Palmisano WA, Michels R, Carstea E, Gabrielson E, Herman JG, Baylin SB, Belinsky SA . 1998 Proc. Amer. Assoc. Cancer Res. 39, 94
Reynisdottir I, Polyak K, Iavarone A, Massague J . 1995 Genes Dev. 9: 1831–1845
Rhee CH, Hess K, Jabbur J, Ruiz M, Yang Y, Chen S, Chenchik A, Fuller GN, Zhang W . 1999 Oncogene 18: 2711–2717
Rodenhuis S, Slebos R, Boot AJ, Evers SG, Mooi WJ, Wagenaar SS, van Bodegom PC, Bos JL . 1988 Cancer Res. 48: 5738–5741
Sherr CJ, Roberts JM . 1999 Genes Dev. 13: 1501–1512
Shimizu M, Nomura Y, Suzuki H, Ichikawa E, Taceuchi A, Suzuki M, Nakamura T, Nakajima T, Oda K . 1998 Exp. Cell Res. 239: 93–103
Shiseki M, Kohno T, Nishikawa L, Sameshima Y, Mizoguchi H, Yokota J . 1994 Cancer Res. 54: 5643–5648
Sneath RJ, Mangham DC . 1998 Mol. Pathol. 51: 191–200
Sozzi G, Miozzo M, Donghi R, Pilotti S, Cariani CT, Pastorino U, Della Porta G, Pierotti MA . 1992 Cancer Res. 52: 6079–6082
Sriuranpong V, Borges MW, Ravi RK, Arnold DR, Nelkin BD, Baylin SB, Ball DW . 2001 Cancer Res. 61: 3200–3205
Sueoka N, Lee HY, Wiehle S, Cristiano RJ, Fang B, Ji L, Roth JA, Hong WK, Cohen P, Kurie JM . 2000 Oncogene 19: 4432–4436
Tisdale EJ, Jackson MR . 1998 J. Biol. Chem. 273: 17269–17277
Volm M, Koomagi R . 2000 Br. J. Cancer 82: 1747–1754
Xu HG, Hu SX, Cagle PT, Moore GE, Benedict WF . 1991 Cancer Res. 51: 2735–2739
Yang X, Chernenko G, Hao Y, Ding Z, Pater MM, Pater A, Tang SC . 1998 Oncogene 17: 981–989
Acknowledgements
We are grateful to G Stoner for critical reading of this manuscript and helpful discussions. We thank Elizabeth Wiley for secretarial assistance. This work was supported by NIH grants CN05113, CA58554 and CA78797.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yao, R., Wang, Y., Lubet, R. et al. Differentially expressed genes associated with mouse lung tumor progression. Oncogene 21, 5814–5821 (2002). https://doi.org/10.1038/sj.onc.1205422
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205422
Keywords
This article is cited by
-
FasL −844T/C and Fas −1377G/A: mutations of pulmonary adenocarcinoma in South China and their clinical significances
Tumor Biology (2015)
-
Recent insights into the actions of IGFBP-6
Journal of Cell Communication and Signaling (2015)
-
The clinical and biological significance of STAT1 in esophageal squamous cell carcinoma
BMC Cancer (2014)
-
Identification of IGFBP-6 as an effector of the tumor suppressor activity of SEMA3B
Oncogene (2008)
-
Budesonide exerts its chemopreventive efficacy during mouse lung tumorigenesis by modulating gene expressions
Oncogene (2004)